Moreover, it is also documented that the levels of tau oligomerization are elevated prior to NFTs formation in the brain of AD patients supporting a dynamic relationship between tau oligomerization and the progression of tauopathy in AD brains [10, 11]. The gene discussed is MAPT; the disease is Alzheimer disease.